In this episode of Life Science Success, my guest is Dr Paul Song. Dr. Song has served as Chief Executive Officer and Vice Chairman of NKGen since December 2022.
- Dr. Paul Song, CEO and Vice Chairman of NKGen since December 2022, shares his background as a radiation oncologist and his journey into biotech.
- Dr. Song talks about the importance of natural killer cells in the body’s defense against diseases and their potential in treating conditions like Alzheimer’s.
- NKGen’s phase one trial showed promising results, with 90% of patients either stabilizing or improving in Alzheimer’s treatment.
- NKGen is also exploring the use of natural killer cells in combination with other cancer therapies to enhance their effectiveness while minimizing side effects.